LORD, ABBETT & CO. LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$2,912
-100.0%
467,466
+408.7%
0.01%
-50.0%
Q1 2018$6,647,000
-56.2%
91,887
-60.1%
0.02%
-53.5%
Q4 2017$15,173,000
+28.3%
230,452
-2.3%
0.04%
+22.9%
Q3 2017$11,823,000
+83.8%
235,889
+69.7%
0.04%
+84.2%
Q2 2017$6,432,000138,9770.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$33,967,00011.67%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$20,644,0000.58%
Bellevue Group AG 4,519,164$54,455,0000.55%
Rhenman & Partners Asset Management AB 622,267$7,498,0000.53%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 47,534$573,0000.21%
WASATCH ADVISORS LP 3,274,360$39,456,0000.16%
EMC Capital Management 27,566$246,0000.14%
PDT Partners, LLC 120,828$1,456,0000.10%
Virtus ETF Advisers LLC 17,773$214,0000.09%
Pinz Capital Management, LP 15,300$184,0000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders